12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, several healthcare stocks experienced significant movements. Redhill Biopharma (RDHL) saw a sharp increase of 118.7%, while Tharimmune (THAR) and Apollomics (APLM) rose by 39.13% and 33.37%, respectively. Conversely, Impel Pharmaceuticals (IMPL) and Nuwellis (NUWE) saw declines of 17.7% and 16.69%. Other notable movers included 60 Degrees (SXTP), Sunshine Biopharma (SBFM), Olema Pharmaceuticals (OLMA), Envoy Medical (COCH), Kura Oncology (KURA), SenesTech (SNES), and Kiora Pharmaceuticals (KPRX).
November 27, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Apollomics' stock rose 33.37% to $1.33, with the company's market cap at $119.0 million.
Apollomics' significant pre-market increase could attract more investor attention, potentially leading to further short-term price appreciation.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Redhill Biopharma's stock soared 118.7% in pre-market trading with a market cap of $7.6 million.
The substantial pre-market gain for RDHL indicates a strong positive investor sentiment, which could lead to further short-term price increases if the momentum continues.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Tharimmune's shares increased by 39.13% to $4.0, with a market cap of $2.8 million.
The significant pre-market rise in THAR's stock price suggests positive news or investor expectations, which could lead to further short-term gains.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Impel Pharmaceuticals' shares fell by 17.7% to $0.69, with a market cap of $16.6 million.
The pre-market decline for IMPL could indicate negative sentiment or disappointing news, which may lead to further short-term downside.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Nuwellis' stock decreased by 16.69% to $0.5, with a market cap of $1.6 million.
Nuwellis' stock price drop in pre-market trading could reflect investor concerns or negative developments, potentially leading to further short-term declines.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 100